keyword
https://read.qxmd.com/read/38635089/rapid-metabolism-underlying-subtherapeutic-serum-levels-of-atypical-antipsychotics-preceding-clozapine-treatment-a-retrospective-analysis-of-real-world-data
#21
JOURNAL ARTICLE
Hasan Çağın Lenk, Robert Løvsletten Smith, Kevin S O'Connell, Ole A Andreassen, Espen Molden
INTRODUCTION: Adequate antipsychotic treatment intensity is required before diagnosing resistant schizophrenia and initiating clozapine treatment. We aimed to investigate potential rapid drug metabolism underlying low dose-adjusted serum concentration (CD) of non-clozapine atypical antipsychotics preceding clozapine treatment. METHODS: Patients using non-clozapine, atypical antipsychotics (aripiprazole, risperidone, olanzapine, or quetiapine) within 1 year before starting clozapine were included in this study from a therapeutic drug monitoring service in Oslo, Norway, between 2005 and 2023...
April 18, 2024: CNS Drugs
https://read.qxmd.com/read/38633733/psychotropic-management-in-cotard-syndrome-case-reports-supporting-dual-medication-management
#22
Adam J Fusick, Chemar Davis, Steven Gunther, Cory Klippel, Gregory Sullivan
Cotard syndrome is a rare presentation where patients present with nihilistic thoughts of dying or already being dead. These delusions manifest from either a medical or psychiatric etiology and can be difficult to treat. Recently Couto and Gonçalves purposed that treatment should include an atypical antipsychotic alone or in combination with either a mood stabilizer or antidepressant. Here the authors advocate for a more specific but well-known psychotropic regimen, namely the combination of olanzapine and fluoxetine...
2024: Case Reports in Psychiatry
https://read.qxmd.com/read/38627211/thirst-and-drugs-a-study-in-the-world-health-organization-s-pharmacovigilance-database
#23
JOURNAL ARTICLE
Jean-Louis Montastruc
Thirst is a complex physiological compensatory mechanism but could also be associated with drugs. This association was poorly investigated previously. Using the WHO global pharmacovigilance database, Vigibase®, disproportionality analyses potential associations between exposure to drugs and thirst reports were performed. All reports of thirst in adults between 01/01/2000 and 31/12/2023 were included. Results are expressed as reporting odds ratio (ROR). Analysis of the 3186 reports of thirst (978 'serious') allowed, first, to confirm the association between thirst and exposure to vasopressin antagonists (tolvaptan), lithium, gliflozins (dapagliflozin, empagliflozin), pregabalin and antimuscarinic drugs (glycopyronium, oxybutynin, tiotropium)...
April 16, 2024: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/38618207/effect-of-antipsychotics-and-mood-stabilisers-on-metabolism-in%C3%A2-bipolar-disorder-a-network-meta-analysis-of-randomised-controlled-trials
#24
JOURNAL ARTICLE
Lingzhuo Kong, Huaizhi Wang, Ning Yan, Chenyue Xu, Yiqing Chen, Yuanyuan Zeng, Xiaonan Guo, Jing Lu, Shaohua Hu
BACKGROUND: Antipsychotics and mood stabilisers are gathering attention for the disturbance of metabolism. This network meta-analysis aims to evaluate and rank the metabolic effects of the commonly used antipsychotics and mood stabilisers in treating bipolar disorder (BD). METHODS: Registries including PubMed, Embase, Cochrane Library, Web of Science, Ovid, and Google Scholar were searched before February 15th, 2024, for randomised controlled trials (RCTs) applying antipsychotics or mood stabilisers for BD treatment...
May 2024: EClinicalMedicine
https://read.qxmd.com/read/38617187/risk-factors-associated-with-chemotherapy-induced-nausea-and-vomiting-among-women-with-breast-cancer-receiving-highly-emetogenic-chemotherapy-individual-patient-based-analysis-of-three-prospective-antiemetic-trials
#25
JOURNAL ARTICLE
Winnie Yeo, Nicole T Y Ngai, Christopher C H Yip, Frankie K F Mo, Victoria A Yeo, Jonathan W H Ko, Leung V Li, Thomas K H Lau, Kwai Tung Lai, Elizabeth Pang, Claudia H W Yip, Horatio L Yeo, Carol Chi Hei Kwok, Stephanie W Y Ko, Alex Molassiotis
PURPOSE: Although risk factors related to chemotherapy-induced nausea and vomiting (CINV) have been identified in previous studies, only a few studies have evaluated the risk factors associated with contemporary antiemetic prophylaxis, including olanzapine/aprepitant- or NEPA-containing regimens. This study aimed to identify the risk factors associated with CINV development in Chinese breast cancer patients receiving doxorubicin and cyclophosphamide chemotherapy. METHODS: Data from 304 patients enrolled in 3 previously reported prospective antiemetic studies were included...
2024: Cancer Management and Research
https://read.qxmd.com/read/38610838/association-of-antipsychotic-polypharmacy-and-two-year-all-cause-mortality-a-population-based-cohort-study-of-33-221-italian-continuous-users
#26
JOURNAL ARTICLE
Alberto Parabiaghi, Matteo Monzio Compagnoni, Barbara D'Avanzo, Giulia Caggiu, Alessia A Galbussera, Mauro Tettamanti, Ida Fortino, Angelo Barbato
Background: Differences in survival between patients treated with antipsychotic monotherapy vs. polytherapy are debated. This study aimed to examine the association of antipsychotic polytherapy with 2-year all-cause mortality in a population-based cohort. Methods: Data were retrieved from healthcare databases of four local health units of Lombardy, Italy. Subjects aged 18-79 years who received continuous antipsychotic prescriptions in 2018 were identified. Overall survival among patients with antipsychotic monotherapy vs...
April 3, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38607458/antipsychotic-prescribing-national-findings-of-children-and-adolescents-attending-mental-health-services-in-ireland
#27
JOURNAL ARTICLE
David J O Driscoll, Suzanne McCarthy
Antipsychotic prescribing trends vary internationally, albeit off-label use remains high (i.e., target symptoms). We aim to describe antipsychotic use, target conditions, target symptoms and dosing regimens in children and adolescents in Ireland. We used a sampled cohort from a national audit of children and adolescents attending mental health services with predefined inclusion and exclusion criteria from Jul-2021 to Dec-2021 who were prescribed at least one psychotropic medication and up to and including 17-years of age (n = 3528)...
April 12, 2024: European Child & Adolescent Psychiatry
https://read.qxmd.com/read/38599435/mucoadhesive-chitosan-poly-lactic-co-glycolic-acid-nanoparticles-for-intranasal-delivery-of-quetiapine-development-characterization-in-physiologically-relevant-3d-tissue-models
#28
JOURNAL ARTICLE
Dnyandev G Gadhave, Mural Quadros, Akanksha R Ugale, Mimansa Goyal, Seyoum Ayehunie, Vivek Gupta
Quetiapine hemifumarate (QF) delivery to the CNS via conventional formulations is challenging due to poor solubility and lower oral bioavailability (9 %). Similarly, many other second-generation antipsychotics, such as olanzapine, clozapine, and paliperidone, have also shown low oral bioavailability of <50 %. Hence, the present work was intended to formulate QF-loaded biodegradable PLGA-NPs with appropriate surface charge modification through poloxamer-chitosan and investigate its targeting potential on RPMI-2650 cell lines to overcome the limitations of conventional therapies...
April 8, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38582275/continuous-oral-olanzapine-or-clozapine-treatment-initiated-in-adolescence-has-differential-short-and-long-term-impacts-on-antipsychotic-sensitivity-than-those-initiated-in-adulthood
#29
JOURNAL ARTICLE
Ruiyong Wu, Shinnyi Chou, Ming Li
One of the major discoveries in recent research on antipsychotic drugs is that antipsychotic treatment in adolescence could induce robust long-term alterations in antipsychotic sensitivity that persist into adulthood. These long-term impacts are likely influenced by various factors, including the "diseased" state of animals, sex, type of drugs, mode of drug administration, and age of treatment onset. In this study we compared the short- and long-term behavioral effects of 21-day continuous oral olanzapine (7...
April 4, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38579432/antipsychotic-medications-and-sleep-problems-in-patients-with-schizophrenia
#30
JOURNAL ARTICLE
Erik Cederlöf, Minna Holm, Heidi Taipale, Jari Tiihonen, Antti Tanskanen, Markku Lähteenvuo, Kaisla Lahdensuo, Olli Kampman, Asko Wegelius, Erkki Isometsä, Tuula Kieseppä, Aarno Palotie, Jaana Suvisaari, Tiina Paunio
BACKGROUND: Sleep problems are common and related to a worse quality of life in patients with schizophrenia. Almost all patients with schizophrenia use antipsychotic medications, which usually increase sleep. Still, the differences in subjective sleep outcomes between different antipsychotic medications are not entirely clear. METHODS: This study assessed 5466 patients with schizophrenia and is part of the nationwide Finnish SUPER study. We examined how the five most common antipsychotic medications (clozapine, olanzapine, quetiapine, aripiprazole, and risperidone) associate with questionnaire-based sleep problems in logistic regression analyses, including head-to-head analyses between different antipsychotic medications...
April 4, 2024: Schizophrenia Research
https://read.qxmd.com/read/38579267/treating-schizophrenia-and-bipolar-i-disorder-in-the-real-world-setting-effectiveness-and-safety-of-olanzapine-samidorphan-combination
#31
JOURNAL ARTICLE
Maxwell Zachary Price, Richard Louis Price
No abstract text is available yet for this article.
April 2, 2024: Primary Care Companion to CNS Disorders
https://read.qxmd.com/read/38579062/a-case-report-of-a-patient-with-turner-syndrome-who-develops-catatonia-secondary-to-psychotic-symptoms
#32
JOURNAL ARTICLE
Yong Xia, Yuyong Sun, Qianna Zhi, Wenjing Cui, Xiaoyan Liu
RATIONALE: Turner syndrome (TS) is a genetic disorder associated with partial or complete monosomy X abnormalities; some patients may have a higher risk of psychiatric symptoms. Catatonia is associated with a wide range of life-threatening complications with complex pathogenesis; However, It very rare for patients with TS to develop psychotic symptoms and eventually progress to catatonia. This case report describes the diagnostic and therapeutic course of catatonia-associated TS. PATIENT CONCERNS: In this study, we report the case of a patient with TS who initially developed sudden hallucinations, delusions, and emotional instability, followed by catatonia...
April 5, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38578194/pragmatic-clinical-trials-to-advance-research-in-children-and-adolescents-with-eating-disorders
#33
JOURNAL ARTICLE
Mark L Norris, Wendy Spettigue, Nicole Obeid
OBJECTIVE: To discuss the utility of pragmatic clinical trials (PCTs) to help advance research in eating disorders (EDs). METHODS: We describe challenges associated with traditional explanatory research trials and examine PCTs as an alternative, including a review of the PRECIS-2 tool. RESULTS: There are many challenges associated with the design and completion of traditional RCTs within the field of EDs. Pragmatic clinical trials are studies that closely align with conditions available in everyday practice and focus on outcomes that are relevant to patients and clinicians...
April 5, 2024: International Journal of Eating Disorders
https://read.qxmd.com/read/38577400/machine-learning-for-prediction-of-violent-behaviors-in-schizophrenia-spectrum-disorders-a-systematic-review
#34
Mohammadamin Parsaei, Alireza Arvin, Morvarid Taebi, Homa Seyedmirzaei, Giulia Cattarinussi, Fabio Sambataro, Alessandro Pigoni, Paolo Brambilla, Giuseppe Delvecchio
BACKGROUND: Schizophrenia spectrum disorders (SSD) can be associated with an increased risk of violent behavior (VB), which can harm patients, others, and properties. Prediction of VB could help reduce the SSD burden on patients and healthcare systems. Some recent studies have used machine learning (ML) algorithms to identify SSD patients at risk of VB. In this article, we aimed to review studies that used ML to predict VB in SSD patients and discuss the most successful ML methods and predictors of VB...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38576571/effects-of-cyp2d6-gene-polymorphism-on-plasma-concentration-and-therapeutic-effect-of-olanzapine
#35
JOURNAL ARTICLE
Ye Yang, Wenqing Liu, Renrong Wu
This study aimed to evaluate the relationship between gene polymorphisms of metabolic enzymes, particularly the CYP2D6 gene, and the plasma concentration of olanzapine, as well as treatment response in patients with chronic schizophrenia. We recruited olanzapine-treated patients and examined their plasma olanzapine levels. Additionally, a common mutation site within each of the nine exons of the full-length CYP2D6 sequence was assayed. The Positive and Negative Syndrome Scale, Brief Psychiatric Rating Scale, and Overall Clinical Impression were used to assess schizophrenic symptoms, whereas the Barnes Akathisia Scale and Extrapyramidal Symptom Rating Scale were used to evaluate adverse effects...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38576166/antipsychotic-drugs-in-first-episode-psychosis-a-target-trial-emulation-in-the-fep-causal-collaboration
#36
JOURNAL ARTICLE
Alejandro G Szmulewicz, Gonzalo Martínez-Alés, Roger Logan, Maria Ferrara, Christian Kelly, Diane Fredrikson, Juan Gago, Sarah Conderino, Covadonga M Díaz-Caneja, Joaquín Galvañ, Lorna Thorpe, Vinod Srihari, Lakshmi Yatham, Deepak K Sarpal, Ann K Shinn, Celso Arango, Dost Öngür, Miguel A Hernán, On Behalf Of The Fep-Causal Collaboration
Good adherence to antipsychotic therapy helps prevent relapses in First Episode Psychosis (FEP). We used data from the FEP-CAUSAL Collaboration, an international consortium of observational cohorts to emulate a target trial comparing antipsychotics with treatment discontinuation as the primary outcome. Other outcomes included all-cause hospitalization. We benchmarked our results to estimates from EUFEST, a randomized trial conducted in the 2000s. We included 1097 patients with a psychotic disorder and less than 2 years since psychosis onset...
April 3, 2024: American Journal of Epidemiology
https://read.qxmd.com/read/38576143/drugs-for-bipolar-disorder
#37
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 1, 2024: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/38566958/case-report-avoiding-intolerance-to-antipsychotics-through-a-personalized-treatment-approach-based-on-pharmacogenetics
#38
Liam Korošec Hudnik, Tanja Blagus, Sara Redenšek Trampuž, Vita Dolžan, Jurij Bon, Milica Pjevac
INTRODUCTION: The standard approach to treatment in psychiatry is known as "treatment as usual" (TAU), in which the same types of treatment are administered to a group of patients. TAU often requires numerous dose adjustments and medication changes due to ineffectiveness and/or the occurrence of adverse drug reactions (ADRs). This process is not only time-consuming but also costly. Antipsychotic medications are commonly used to treat various psychiatric disorders such as schizophrenia and mood disorders...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38563025/the-influence-of-concomitant-antidepressant-and-antipsychotic-medication-on-antidepressant-effect-and-seizure-duration-of-electroconvulsive-therapy
#39
JOURNAL ARTICLE
Sara Mohamad, Samuel Trumm, Sascha Treskatsch, Alisha Drevs, Malek Bajbouj, Leonardo Wiedemann
BACKGROUND: A significant proportion of patients with a depressive disorder show resistance to pharmacological and psychotherapeutic antidepressant treatments. Electroconvulsive therapy (ECT) is still one of the most effective treatment methods, especially in the acute phase. In everyday clinical practice, this usually accompanies pharmacological treatment. It has been shown that pharmacological treatment following acute ECT treatment reduces the rate of relapses. However, the effect of various antidepressants (ADs) and antipsychotics (APs) on the effect during the course of ECT has rarely been investigated...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38562098/tongue-edema-as-an-adverse-drug-reaction-to-low-dose-olanzapine-in-a-cancer-patient-receiving-palliative-care
#40
JOURNAL ARTICLE
Matteo Moroni, Eduardo Bruera
OBJECTIVES: Olanzapine is an atypical neuroleptic indicated for treatment of various psychiatric disorders, but it has also several indications in palliative care (PC) patients: opioids misuse, nausea not related to chemotherapy, anorexia-cachexia syndrome, and sleep and mood disorders. Peripheral and facial edema are a rare side effect of the treatment with olanzapine. I report a case of an advanced cancer patient cared receiving PC who developed moderate tongue edema on day 1 of a low dose of olanzapine...
April 2, 2024: Palliative & Supportive Care
keyword
keyword
4834
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.